In this issue, guest editors bring their considerable expertise to this important topic.
Key Features
-
Contains 10 relevant, practice-oriented topics including current dedicated breast imaging: recent advances and current limitations; breast cancer systemic staging (comparison of CT, bone scan, FDG PET); breast cancer treatment response (comparison of CT, bone scan, FDG PET); artificial intelligence and machine learning in breast cancer imaging; molecular classification of breast cancer; and more.
-
Provides in-depth clinical reviews on breast cancer: advances in molecular imaging, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Gary A. Ulaner, MD, PhD, FACNM, Associate Attending Radiologist, Memorial Sloan Kettering Cancer Center, New York, New York and Amy M. Fowler, MD, PhD, FSBI, Assistant Professor, Section of Breast Imaging and Intervention, Department of Radiology, University of Wisconsin – Madison
Molecular Classification of Breast Cancer
Breast Cancer Screening and Diagnosis: Recent Advances in Imaging and Current Limitations
Metabolic Positron Emission Tomography in Breast Cancer
Molecular Breast Imaging and Positron Emission Mammography
Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography)
Evaluation of Treatment Response in Patients with Breast Cancer
Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer
Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 PET Imaging: Challenges and Opportunities
Other Novel PET Radiotracers for Breast Cancer
AI-Enhanced PET and MR Imaging for Patients with Breast Cancer
